✦ LIBER ✦

Micronodular basal cell carcinoma: A distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas

✍ Scribed by Roberto BETTI; Silvano MENNI; Giovanni RADAELLI; Caterina BOMBONATO; Carlo CROSTI

Book ID: 108576694
Publisher: John Wiley and Sons
Year: 2010
Tongue: French
Weight: 127 KB
Volume: 37
Category: Article
ISSN: 0385-2407
DOI: 10.1111/j.1346-8138.2009.00772.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SHORT COMMUNICATIONPhotodynamic therapy

SHORT COMMUNICATIONPhotodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique

✍ M.R.T.M. Thissen; C.A. Schroeter; H.A.M. Neumann 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

The incidence of basal cell carcinomas (BCCs) is still increasing, and there is a demand for an easy, effective and selective non-invasive treatment such as topical photodynamic therapy (PDT). Twenty-three patients with 24 nodular BCCs were treated once with delta-aminolaevulinic acid (delta-ALA) PD

Letter: Destructive Basal Cell Carcinoma

Letter: Destructive Basal Cell Carcinoma in a Patient with Basal Cell Nevus Syndrome and an Interstitial Deletion of Chromosome 9q22

✍ KLARA MOSTERD; ANJA SOMMER; ARIENNE VAN MARION; MARTIN LACKO; JOS HERBERGS; BERT 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Imiquimod induced regression of clinical

Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells

✍ R. St. C. Barnetson; A. Satchell; L. Zhuang; H. B. Slade; G. M. Halliday 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Superficial radiotherapy for patients wi

Superficial radiotherapy for patients with basal cell carcinoma : Recurrence rates, histologic subtypes, and expression of p53 and Bcl-2

✍ Beate Zagrodnik; Werner Kempf; Burkhardt Seifert; Beatrix Müller; Günter Burg; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract ## BACKGROUND The histologic subtype of a basal cell carcinoma (BCC) may be an important factor for the success of a certain treatment modality. In the current article, the authors report recurrence rates among patients with BCC after superficial radiotherapy as well as Bcl‐2 and p53 e

Polymorphisms in the DNA repair gene XRC

Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population

✍ Sang Yoon Kang; Kwang Gil Lee; Wooseung Lee; Jeong Yun Shim; Seung Il Ji; Ki Wha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Imiquimod 5% cream for the treatment of

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

✍ W. Sterry; T. Ruzicka; E. Herrera; A. Takwale; J. Bichel; K. Andres; L. Ding; M. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Background: Imiquimod 5% cream has been investigated for non-surgical treatment of superficial and nodular basal cell carcinoma (bcc) tumours. ## Objectives: Two studies were conducted to examine the effect of occlusion at low dosing frequencies on the safety and efficacy of topical imiquimod